Tofacitinib (CP-690,550), An Oral Janus Kinase Inhibitor, in Combination with Methotrexate Reduced the Progression of Structural Damage in Patients with Rheumatoid Arthritis: a 24-Month Phase 3 Study

Author(s):
Heijde, D. van der; Tanaka, Y.; Fleischmann, R.; Keystone, E.C.; Kremer, J.M.; Zerbini, C.A.F.; Cardiel, M.; Cohen, S.B.; Nash, P.T.; Song, Y.W.; Tegzova, D.; Wyman, B.; Gruben, D.; Benda, B.; Wallenstein, G.; Zwillich, S.H.; Bradley, J.D.; Connell, C.A.; ORAL Scan Investigators
Published
2011
Publication type
Article / Letter to editor
Date issued
2011-10-31
Language
English
Is part of
Arthritis and Rheumatism (2011), Vol. 63, no. 10, p. S1017-S1018
hdl
1887/106212